ASCO’s First-Ever Clinical Trial: The TAPUR Study

July 28th 2016

The Targeted Agent and Profiling Utilization Registry (TAPUR) study is evaluating molecularly targeted cancer drugs and collecting data on clinical outcomes to learn about additional uses of these drugs outside of indications already approved by the FDA. Learn more at http://www.tapur.org